Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04526145 · ClinicalTrials.gov registry record · NA

OUR Stress/ Emotion Management for Black/African American Women With Hypertension

A NA study of Stress, Psychological, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT04526145: Completed NA study of Stress, Psychological, sponsored by Ohio State University.

NCT04526145 is a NA study of Stress, Psychological that has completed, run by Ohio State University. The registered enrollment target is 16 participants, below the 171-participant average among 43 other Stress, Psychological trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04526145, a NA study of Stress, Psychological, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

Covid-19 is an additional stressor Black women have to deal with that may interfere with hypertension self-care management. Social connectedness is a source of resilience for Black women to promote mental and physical health. Unfortunately, in the face of the Covid-19 pandemic, social distancing is a challenge further isolating Black women from their networks. How is social connectedness to manage stress and emotional well-being in a social-distancing society for Black women with hypertension? The research team proposed a synchronous web-based version of Enhanced Co-Created Health Education InterventioN (eCo-CHIN) that build the success and best practices derived from the original intervention. A Covid-19 session will be included as a way of helping Black women to maintain resilience and self-care during stressful times. The eCo-CHIN intervention is innovative and timely because the research team are using a synchronous platform preparing Black women on how to deal with Covid-19 while taking care of self. The primary investigator for this pilot study (Dr. Wright) is a Black Early Stage Investigator and former KL2 (career development) awardee. The interdisciplinary research team has the expertise and resources to deliver this Enhanced Co-CHIN intervention.

Primary Outcome

Weekly participant attendance will be recorded as date, month and year.

Conditions Studied

Interventions

  • BEHAVIORAL Stress and emotion management

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2021-05-01
Est. Completion 2024-12-31
Phase NA
Ohio State University

552 total trials

What the finished NCT04526145 record still lists

NCT04526145 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 171-participant average among 43 other Stress, Psychological trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Stress, Psychological appearing as the primary indexed condition, and to 1 intervention - of which Stress and emotion management is the first listed.

NCT04526145 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04526145 about?

NCT04526145 is a clinical study titled "OUR Stress/ Emotion Management for Black/African American Women With Hypertension". Covid-19 is an additional stressor Black women have to deal with that may interfere with hypertension self-care management. Social connectedness is a source of resilience for Black women to promote mental and physical health. Unfortunately, in the face of the Covid-19 pandemic, social distancing is ...

What is the current status of trial NCT04526145?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2021-05-01. Estimated completion is 2024-12-31.

What conditions does trial NCT04526145 study?

This clinical trial studies the following conditions: Stress, Psychological.

What interventions are being tested in trial NCT04526145?

The interventions under investigation include: Stress and emotion management (BEHAVIORAL).

Who is sponsoring clinical trial NCT04526145?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04526145 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress, Psychological

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04526145's enrollment target sits among peer trials

16 44th of 43 the lowest of 43 other Stress, Psychological trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress, Psychological trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04526145, the US trial registry maintained by the National Library of Medicine. NCT04526145 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.